Heat Biologics Inc. (HTBX) Declined -18.46% or -0.48 To Price $2.12 On Tuesday


Heat Biologics Inc. (HTBX) declined -18.46% or -0.48 to $2.12. It is about 3.37 million shares traded, which is 86.03% compare to the average total volume 3.92 million. The market cap of HTBX is $44.11 million. The year to date change is -1879.53%. The 52 week price range is from $1.09 to $7.89. Price of HTBX have changed 10.64% during last week. It have changed 96.97% over last month, 29.35% over last 3 months, -25.76% over last 6 months and -60.00% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HTBX is 1.72. It is -18.87% below current price. The 200-day Moving Averages for HTBX is 3.73. It is 75.94% above current price. The 52-week High is 7.89. It is 272.17% from the current price. The 52-week Low is 1.09. It is -48.58% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of HTBX is 0.24 on 2018-05-15. Short % to float is 4.42%. There are some statistics of HTBX. It is has market cap $44.11 million. The share outstanding is 20.81 million. The average volume is 3.92 million. The revenue is 882073. The percent of top 15 Institution holding is 2.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HTBX is -112.47%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HTBX is -73.00%.


Tags:

Share this post